Podcasts
Episode 17 of The Conversational Flow podcast, hosted by Brian Wile and Adam Cotty, dives into the evolving landscape of flow cytometry networking and regulatory guidance, where they analyze recent FDA biomarker validation guidance, comparing it to existing industry standards like CLSI H62. Our hosts explore the challenges of harmonizing flow cytometry…
Blogs
If you have trained in the field of immunology, it may not be uncommon to emerge with a self-characterization as either a “B-cell immunologist” or a “T-cell immunologist.” Historically, this distinction arose from years of specialization and the degrees of separation between T-cell and B-cell biology research. Approaches to therapeutic…
Blogs
What is a generic PK assay? A generic pharmacokinetic (PK) assay, also referred to as a universal PK assay for New Biologic Entities (NBE), is used to measure circulating human biotherapeutics—primarily antibody-based—post-administration across various non-human matrices. These assays are particularly beneficial when drug-specific reagents, such as anti-idiotype antibodies, are…
Blogs
At KCAS Bio, we don’t just advance science—we cultivate an environment where talented professionals thrive. Our success is driven not only by groundbreaking innovation but also by a workplace culture that values and supports our people. We believe that when employees are engaged, motivated, and happy, they perform at their…
Blogs
KCAS Bio is excited to expand our global reach by attending key conferences across Europe in 2025. These events bring together top experts in biotechnology, pharmaceuticals, and clinical research, providing a unique opportunity to discuss cutting-edge advancements, regulatory insights, and innovative solutions in bioanalytical and biomarker services. As we continue…
June 12
- June 13
KCAS Bio is pleased to announce its participation in the EBF Spring Focus Workshop, taking place June 12–13, 2025, in Málaga, Spain. This specialized event, organized by the European Bioanalysis Forum (EBF), offers a unique platform for industry leaders, scientists, and regulatory experts to discuss the latest advancements and challenges…
June 26
- June 26
KCAS Bio is excited to announce our participation in the Healthtech Accelerations Summit (HAS) 2025, taking place on June 26 in Paris, France. This prestigious event brings together global leaders in biotechnology, pharmaceuticals, and digital health to discuss the latest breakthroughs, investment opportunities, and regulatory advancements shaping the future of…
May 5
- May 6
KCAS Bio is excited to announce our participation in Swiss Biotech Day 2025, taking place in Basel, Switzerland, on May 5-6. As one of the leading biotechnology conferences in Europe, this event brings together industry leaders, investors, and scientific pioneers to discuss the latest developments shaping the future of biotech…
Podcasts
Dom and John, the hosts of “The Weekly Bioanalysis”, recently returned from EBF in Barcelona where there was a session on Patient-centric Microsampling, which both of them found fascinating. This inspired both of them to decide it was high time to revisit this part of our industry. In spite of…
Blogs
Antibody drug conjugates (ADCs) are important targeted therapies in oncology. These are complex moieties consisting of a cell-targeting antibody combined with an active payload through a chemical linker. Key Components to Monitor in PK Studies Two significant components to monitor for PK studies are the (1) intact antibody drug conjugate…
Blogs
KCAS Bio launched an initiative to advance its Quality System through a 21 CFR Part 11 compliant electronic Quality Management System (eQMS) to be prepared for anticipated future regulatory requirements for Good Laboratory Practice (21 CFR 58). This was driven by the proposed rule from August 2016, the FDA is…
Blogs
KCAS Bio is thrilled to announce our participation in several key scientific and bioanalytical events across the United States in the coming months. These conferences provide a unique platform to showcase our cutting-edge capabilities, engage with industry leaders, and explore innovative approaches to bioanalysis. From gene therapy to toxicology and…